NASDAQ:KRYS

Krystal Biotech Stock Signals

etoro logo Buy KRYS
*Your capital is at risk
$208.25
+2.09 (+1.01%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 6.506 46 days ( -33.74 % )
Last Price $208.25 1.01 %
High/ Low $205.57 - $212.73 7.59%
Chg 7 Days 4.37 % $199.53 $208.25
Chg 30 Days 9.47 % $190.23 $208.25
Chg 12 mos 21.97 % $170.74 $208.25
Trend - 3 mos 47.03 % Width: 14.96 %
Trend - 12 mos -0.122 % Width: 57.64 %
Pred. range - 3 mos $279.06 - $320.82 34.00 % - 54.05 %
Pred. range - 12 mos $123.09 - $194.05 -40.89 % - -6.82 %
Short MA avg 3 mos Sell Oct 28, 2025 - 15 days
Long MA avg 3 mos Buy Sep 12, 2025 - 47 days
Short/Long MA avg 3 mos Buy Sep 16, 2025 - 45 days
Short MA avg 12 mos Sell Oct 28, 2025 - 15 days
Long MA avg 12 mos Buy Sep 10, 2025 - 49 days
Short/Long MA avg 12 mos Buy Sep 02, 2025 - 55 days
Pivot Short Buy Oct 29, 2025 - 14 days
Bollinger Buy Nov 04, 2025 - 10 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT KRYSTAL BIOTECH INC
Krystal Biotech
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive con...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE